Literature DB >> 19553518

Promise and potential pitfalls of anti-VEGF drugs in retinopathy of prematurity.

B A Darlow, C Gilbert, G E Quinn, R Azad, A L Ells, A Fielder, A Zin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19553518     DOI： 10.1136/bjo.2008.156208

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  4 in total

1.  Severe visual impairment and blindness in infants: causes and opportunities for control.

Authors:  Parikshit Gogate; Clare Gilbert; Andrea Zin
Journal:  Middle East Afr J Ophthalmol       Date:  2011-04

2.  NADPH oxidase, NOX1, mediates vascular injury in ischemic retinopathy.

Authors:  Jennifer L Wilkinson-Berka; Devy Deliyanti; Indrajeetsinh Rana; Antonia G Miller; Alex Agrotis; Roksana Armani; Cédric Szyndralewiez; Kirstin Wingler; Rhian M Touyz; Mark E Cooper; Karin A Jandeleit-Dahm; Harald H H W Schmidt
Journal:  Antioxid Redox Signal       Date:  2013-10-30       Impact factor: 8.401

Review 3.  Prevention of blindness due to retinopathy of prematurity: a national movement.

Authors:  Rajvardhan Azad
Journal:  Indian J Pediatr       Date:  2014-05-04       Impact factor: 1.967

4.  Frequency of Ocular Diseases in Infants at a Tertiary Care Hospital.

Authors:  Erum Shahid; Arshad Shaikh; Sina Aziz; Atya Rehman
Journal:  Korean J Ophthalmol       Date:  2019-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.